Extended Varenicline Treatment for Smoking Among Cancer Patients
Extended Duration Varenicline for Smoking Among Cancer Patients: A Clinical Trial
Sponsor: University of Pennsylvania
A PHASE3 clinical study on Nicotine Dependence, this trial is completed. The trial is conducted by University of Pennsylvania and has accumulated 13 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE3
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE3
▶ Show 8 earlier versions
-
Aug 2019 — Jan 2021 [monthly]
Completed PHASE3
-
Jul 2019 — Aug 2019 [monthly]
Completed PHASE3
-
Feb 2019 — Jul 2019 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Aug 2018 — Feb 2019 [monthly]
Active Not Recruiting PHASE3
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting PHASE3
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Apr 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .